# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 501-510 of 561 results.
Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response
Status: Recruiting
Last Changed: Apr 03, 2020
First Received: May 16, 2017
Disease(s): Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Hodgkin
Intervention(s): SENTINEL
Locations: CHBA Vannes, Vannes, Bretagne, France
Institut Bergonié, Bordeaux, Gironde, France
Polyclinique du Parc, Caen, Normandie, France
Institut d'Hématologie de Basse Normandie, Caen, Normandie, France
Hôpital Privé du Confluent, Nantes, Pays De Loire, France
... and 11 other locations.
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20
Status: Recruiting
Last Changed: Dec 16, 2019
First Received: Mar 31, 2017
Disease(s): Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Chronic Lymphocytic Leukemia, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma
Intervention(s): anti-CD19/20-CAR vector-transduced T cells
Locations: Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital, Beijing, Beijing, China
LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
Status: Not yet recruiting
Last Changed: Jul 29, 2020
First Received: Jun 25, 2020
Disease(s): Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Primary
Intervention(s): Lenalidomide, Ibrutinib
Locations: CHU Amiens, Amiens, France
CHU Angers, Angers, France
CHU Besançon, Besançon, France
Institut Bergonié, Bordeaux, France
CHU Caen, Caen, France
... and 21 other locations.
Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects
Status: Recruiting
Last Changed: Jan 15, 2019
First Received: Aug 14, 2018
Disease(s): Lymphoma, Large B-Cell, Diffuse, Mantle Cell Lymphoma, Peripheral T Cell Lymphoma, Double-hit Lymphoma
Intervention(s): Chidamide
Locations: Hematological Department, People's Hospital of Jiangsu Province, Nanjing, Jiangsu, China
Auto Stem Cell Transplant for Lymphoma Patients
Status: Recruiting
Last Changed: Sep 25, 2019
First Received: Apr 24, 2017
Disease(s): Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Intervention(s): Etoposide, BCNU, AraC, Melphalan, Peripheral blood stem cell transplantation, G-CSF, Cyclophosphamide, Total Body Irradiation
Locations: Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance
Status: Recruiting
Last Changed: May 18, 2020
First Received: Nov 06, 2018
Disease(s): DLBCL
Intervention(s): Ibrutinib
Locations: A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia, Alessandria, Italy
Università Politecnica delle Marche- Clinica di Ematologia, Ancona, Italy
Centro Riferimento Oncologico- S.O.C. Oncologia Medica A, Aviano, Italy
IRCCS Istituto Tumori Giovanni Paolo II - U.O.C Ematologia, Bari, Italy
Policlinico S.Orsola-Malpighi - Istituto di Ematologia "Seragnoli", Bologna, Italy
... and 39 other locations.
Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL, NOS
Status: Recruiting
Last Changed: Nov 29, 2019
First Received: Nov 29, 2019
Disease(s): EBV-Positive DLBCL, Nos
Intervention(s): Sintilimab, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone
Locations: ChangZhou First People's Hospital, ChangZhou, Jiangsu, China
ChangZhou No.2 People's Hospital, ChangZhou, Jiangsu, China
HuaiAn First People's Hospital, HuaiAn, Jiangsu, China
Drum tower hospital, Nanjing, Jiangsu, China
The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital), NanJing, Jiangsu, China
... and 7 other locations.
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Status: Recruiting
Last Changed: Feb 12, 2019
First Received: Jul 08, 2009
Disease(s): Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Adult Solid Tumor, Protocol Specific
Intervention(s): 3'-deoxy-3'-[18F]fluorothymidine
Locations: Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement
Status: Recruiting
Last Changed: Jun 16, 2020
First Received: Jun 16, 2020
Disease(s): DLBCL, Untreated, MYC Gene Rearrangement
Intervention(s): Lenalidomide, Rituximab, Etoposide, Doxorubicin, Vincristine, Cyclophosphamide, Prednisone
Locations: The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital), Nanjing, Jiangsu, China
Recommendations for the Treatment of Children With Burkitt's Lymphoma
Status: Not yet recruiting
Last Changed: Jun 18, 2020
First Received: Jun 11, 2020
Disease(s): Burkitt Lymphoma
Intervention(s): OBSERVATIONAL
Locations: CHU de Treichville à ABIDJAN, Abidjan, Côte D'Ivoire